Utilidad pronóstica de las bandas oligoclonales de tipo IgM frente a lípidos en la esclerosis múltiple
S Ribes García - 2023 - riucv.ucv.es
Las bandas oligoclonales (BOC) de tipo IgM en el líquido cefalorraquídeo (LCR) se han
identificado como un marcador de peor pronóstico en la esclerosis múltiple (EM). El objetivo …
identificado como un marcador de peor pronóstico en la esclerosis múltiple (EM). El objetivo …
Biomarcadores de respuesta al interferón beta en la esclerosis múltiple
R Alenda Asensi - 2017 - docta.ucm.es
La esclerosis múltiple (EM) es una enfermedad crónica del sistema nervioso central (SNC)
que se caracteriza por presentar desmielinización, inflamación y daño axonal. El Interferón …
que se caracteriza por presentar desmielinización, inflamación y daño axonal. El Interferón …
Opsoclonus—myoclonus—dysequilibrium syndrome: cytological and immunological dynamics in the serial cerebrospinal fluid in two patients
A Bartoš, J Pitha - Journal of neurology, 2003 - Springer
A peculiar clinical presentation characterized by the triad of opsoclonus, myoclonus and
ataxia, mainly in a form of dysequilibrium, is usually associated with infectious or …
ataxia, mainly in a form of dysequilibrium, is usually associated with infectious or …
Comment on the article by Stauch et al.'Intrathecal IgM synthesis in paediatric MS is not a negative prognostic marker of disease progression: quantitative versus …
LM Villar, JC Alvarez-Cermeño - Multiple Sclerosis Journal, 2012 - search.proquest.com
The article by Stauch et al. 1 addresses two main points: First, they report the inability of
intrathecal IgM synthesis calculated with Reiber's semi-quantitative formula (Reibergram) in …
intrathecal IgM synthesis calculated with Reiber's semi-quantitative formula (Reibergram) in …
Use of rituximab in multiple sclerosis: current progress and future perspectives
D Reske, WF Haupt - Expert Review of Clinical Immunology, 2008 - Taylor & Francis
In recent years, new insights into the immunological pathways in multiple sclerosis (MS)
have been detected. This increasing knowledge has led to more distinct treatment options in …
have been detected. This increasing knowledge has led to more distinct treatment options in …
[PDF][PDF] This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and …
MD Álvarez-Cermeño, A Bar-Or - autoimmun.ru
IgM oligoclonal bands: Biomarker of targetable inflammation in PPMS Page 1 IgM oligoclonal
bands: biomarker of targetable inflammation in PPMS Luisa M Villar 1 , PhD; Bonaventura …
bands: biomarker of targetable inflammation in PPMS Luisa M Villar 1 , PhD; Bonaventura …
[PDF][PDF] Chemiluminescent detection of oligoclonal immunoglobulins after isoelectric focusing and affinity-mediated immunoblotting
O Dlouhy, P Kusnierova, I Kurasova… - Biomedical …, 2018 - biomed.papers.upol.cz
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Jun; 162(2) Page 1
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Jun; 162(2):107-115. 107 …
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Jun; 162(2):107-115. 107 …
B cells set trends: Lessons from multiple sclerosis
S Lawrie, A Bar‐Or - Clinical and Experimental …, 2012 - Wiley Online Library
Until relatively recently, B cells were viewed as relatively passive recipients of T cell help,
serving the primary normal function of protective antibody production. Similarly, their role in …
serving the primary normal function of protective antibody production. Similarly, their role in …
Evidence For The Involvement of B Cells and Antibody in The Pathogenesis of Multiple Sclerosis in Immunized Mouse With Recombinant Myelin Basic Protein Peptide
Over the years, regarding great progresses in knowledge of immunology and neuroscience,
the treatment of multiple sclerosis (MS) has been changed. The earlier strategies were …
the treatment of multiple sclerosis (MS) has been changed. The earlier strategies were …
Multiple Sclerosis: An Autoimmune Disease of the Central Nervous System?
JR Rinker II, RT Naismith, AH Cross - Handbook of Multiple …, 2006 - taylorfrancis.com
Multiple sclerosis (MS) has long been accepted as an inflammatory disease limited to the
central nervous system (CNS). The etiology of the disease, particularly the initial inciting …
central nervous system (CNS). The etiology of the disease, particularly the initial inciting …